- Home
- / Almac Pharma Services
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Almac Pharma Services financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£114.9 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|
| Revenue | 91.3M | 108.3M | 114.9M |
| Cost of goods sold | 62.7M | 74.9M | 75.7M |
| Gross profit | 28.6M | 33.3M | 39.2M |
| Gross profit margin, % | 31.4% | 30.8% | 34.2% |
| General and administrative expense | 16.6M | 16.7M | 19.3M |
| Operating expense total | 20.9M | 21.4M | 23.8M |
| EBIT | 8.0M | 12.0M | 15.5M |
| EBIT margin, % | 8.7% | 11.1% | 13.5% |
| Interest income | 22.5K | 46.7K | 120.3K |
| Interest expense | 439.1K | 762.4K | 464.2K |
| Pre tax profit | 7.6M | 11.3M | 15.1M |
| Income tax expense | 1.4M | 2.6M | 4.3M |
| Net Income | 6.1M | 8.7M | 10.8M |